Skip to main content

Animations

MJFF Publications

3861 - 3870 of 6467 Results
Title
Year
  • Year
  • 2024
  • 2020
  • 2024
  • 2024
  • 2024
  • 2024
  • 2018
  • 2016
  • 2018
  • 2019
  • Summary Details
    OPEN
    Title: Real-World Experiences of Parkinson's Disease OFF Time and Role of Demographics
    Journal Name: Journal of Patient-Centered Research and Reviews
    Publisher: Aurora Health Care, Inc.
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.17294/2330-0698.2057
    Citation Count: 4
  • Summary Details
    OPEN
    Title: MRI-visible perivascular spaces are associated with cerebrospinal fluid biomarkers in Parkinson’s disease
    Journal Name: Aging
    Publisher: Impact Journals, LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.18632/aging.104200
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Levodopa-induced dyskinesia in Parkinson's disease: Insights from cross-cohort prognostic analysis using machine learning
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107054
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Parkinson's disease: Still waiting for a cure
    Journal Name: Clinical and Translational Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/cts.13898
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Biochemical and neurophysiological effects of deficiency of the mitochondrial import protein TIMM50
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.99914.3
    Citation Count: 1
  • Summary Details
    OPEN
    Title: A genetic and proteomic comparison of key AD biomarkers across tissues
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.14139
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter Microstructure
    Journal Name: Frontiers in Endocrinology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fendo.2018.00608
    Citation Count: 20
  • Summary Details
    OPEN
    Title: T2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson’s Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2016.00174
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2018.00560
    Citation Count: 57
  • Summary Details
    OPEN
    Title: White Matter Tract Alterations in Drug-Naïve Parkinson's Disease Patients With Excessive Daytime Sleepiness
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2019.00378
    Citation Count: 12
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.